Strong history of biomedical innovation and partnering​

Aerie Pharmaceuticals and DSM expand collaboration agreement focused on novel drug delivery technology in ophthalmology
2017Dyneema Purity® Black fiber
 Actamax FDA approval to begin pivotal clinical trial for Actamax™ Adhesion Barrier
2016510(k) approval Porcine Pericardium Devices​
2015Dyneema Purity® Radiopaque Cerclage Cable FDA 510(k) clearance
2014In-house medical coating service plant US Dyneema Purity® fiber plant
 Dyneema Purity® 10 dtex fiber and Radiopaque fiber
 PRP Device FDA 510(k) clearance
 Cellular therapy development services
2013Meso Bilayer Surgical Mesh FDA 510(k) clearance
 UHMWPE membrane technology
2012Kensey Nash Acquisition
 Porcine Mesothelium Devices
2011Actamax DSM-DuPont JV
 HQ move to US
 Settable Fiber Reinforced CPC BVFs​
 Porous Beta-TCP Preform BVFs
2010Expanded portfolio for ophthalmic applications​
2009Medivas technology acquisition for Drug Delivery
 Bionate® II PCU
 Next generation UH product
 VitroStealth® non-biofouling coatings
 Dental membrane
 Porcine Dermis Devices
2008Acquisition of The Polymer Technology Group
 Cardiovascular drug delivery development partnership
 Dyneema Purity® fiber for cardiovascular and spinal applications
2007Thrombectomy Catheters
2006First sales Medical Coatings
 Start of UH and drug delivery activities
 BMM Public Private Partnership funded by Dutch government
 Surgical Tools
 Cartilage Repair​
2005Biomedical EBA launched​
2004Dyneema Purity® fiber for knee ligament fixation
 Oriented Self Reinforced Polymer Devices​
2003Dyneema Purity® orthopedic sutures​
2002Medical Coating R&D efforts started in DSM Desotech
2000Degradable foamed polymer devices
 Collagen components​
 DSM Dyneema’s medical R&D efforts​

Our purpose is to create brighter lives for all


Over 30,000 ECM​
devices implanted


Over 100,000 synthetic bone 
grafts manufactured per year​


Serving the Medical Device 
Industry for over 30 years​

Biomedical Brochure

DSM in biomedical: Advanced biomedical solutions to improve lives.

Read more

  • Our products

    Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more